Drug development takes time.
DCB has only been in the job for 4 months, we have a new chair and new team dynamic now focused on the next phase of getting RAC to market.
Let’s all stay positive, wait for the science and the team working hard to get Zantrene to patients, direct questions to the RAC investor hub so that DCB doesn’t have to answer the same questions over and over. Come back in July/August, wait for the news we are expecting. This negative sentiment won’t help anyone, let alone new investors.
Industry news, page-1321
-
- There are more pages in this discussion • 423 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |